Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy.

Sponsor
Hospital Clinic of Barcelona (Other)
Overall Status
Recruiting
CT.gov ID
NCT05553327
Collaborator
(none)
100
1
2
27.1
3.7

Study Details

Study Description

Brief Summary

The aim of the study is to verify whether a multimodal prehabilitation programme prior to robotic radical prostatectomy contributes to a faster recovery of quality of life after surgery, to better functional results (including erectile function and continence) and to less perioperative anxiety.

Single center randomized clinical trial including prostate cancer patients undergoing robotic-assisted radical prostatectomy at the Hospital ClĂ­nic de Barcelona. Patients will be randomized into two groups, one receiving multimodal prehabilitation and the other a control group. Multimodal prehabilitation consists of improving the functional and mental capacity of an individual to cope with a significant stressor, in this case surgery. The design of our prehabilitation program, lasting 4 weeks prior to surgery, consists of three parts; physical state, nutritional state and mental health. In the case of physical condition, a series of supervised and "home-based" exercises (aerobic and functional) will be carried out in addition to specific pelvic floor exercises. The nutritional status will be evaluated by a nutritionist. Diet guidelines will be given and if there are deficiencies they will be supplemented. Regarding mental health, a visit will be made with a psychologist and group and online therapies will be offered. The outcomes will be evaluated before starting the prehabilitation program, at the end of it (just before surgery) and at 4, 8 and 16 weeks after surgery. The outcomes include variables on physical, nutritional and mental state, health-related quality of life (HRQoL), and continence and erectile function.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Multimodal prehabilitation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy. A Randomized Clinical Trial.
Actual Study Start Date :
May 31, 2022
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Sep 1, 2024

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

Experimental: Multimodal prehabilitation

Behavioral: Multimodal prehabilitation
Physical state: individualised physical status will be evaluated by a physiotherapist. A specific training program and pelvic floor exercises sessions will be led by a physiotherapist. Nutritional state: individual nutritional status will be evaluated by a nutritionist and intervention will be done if applicable. A nutrition group session will be held. Mental health: mindfulness group sessions led by psychologists will be held.

Outcome Measures

Primary Outcome Measures

  1. Continence recovery [Week 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op)]

    Change in continence during the prehabilitation program and postoperative recovery. International Consultation on Incontinence Questionnaire (ICIQ) Scoring scale: 0-21 Higher value means worse outcome

  2. Perioperative anxiety levels [Week 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op)]

    Change in perioperative anxiety levels Hospital Anxiety & Depression (HAD ) Scoring scale: 0-21 0-7 = Normal 8-10 = Borderline abnormal (borderline case) 11-21 = Abnormal (case)

Secondary Outcome Measures

  1. Change in physical status by STS [Week 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op)]

    Sit-to-Stand (STS) Time needed for 5 repeated chair rises. Higher time means worse physical status.

  2. Change in physical status by 6MWT [Week 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op)]

    6 Minute Walk Test (6MWT) Distance covered over a time of 6 minutes. Higher time means worse physical status.

  3. Change in perception of physical status [Week 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op)]

    Yale physical activity survey (YPAS) Part 1 - Scoring scale: 0-85680 kcal/week Part 2 - Scoring scale: 0-142 Part 3 - Scoring scale: 0.7-1.3 Higher values indicates higher activity.

  4. Erectile function recovery [Week 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op)]

    International Index Erectile Function (IIEF-5) Change in erectile function during the prehabilitation program and postoperative recovery. Scoring scale: 5-25 22-25: No erectile dysfunction 17-21: Mild erectile dysfunction 12-16: Mild to moderate erectile dysfunction 8-11: Moderate erectile dysfunction 5-7: Severe erectile dysfunction

  5. Change in perceived general quality of life [Week 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op)]

    EORTC QLQ - C30 Scoring scale: 0-100 Higher value indicates higher perceived general quality of life

  6. Change in perceived prostate quality of life [Week 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op)]

    EORTC QLQ - PR25 Scoring scale: 0-100 Higher value indicates higher perceived prostate quality of life

  7. Early postoperative morbidity by CDC [Week 8 (post-op)]

    Clavien-Dindo Classification (CDC) Scoring scale: 1-5 Higher value indicates more severe complication

  8. Early postoperative morbidity by CCI [Week 8 (post-op)]

    Comprehensive Complications Index (CII) Scoring scale: 0-100 Higher value indicates more severe complication

  9. Perceived application usability [Week 4]

    Usability questionare Includes a combination of the System Usability Scale (SUS) and the Net Promoter Score (NPS). Scoring scale: 0-100 Higher value indicates better perceived usability

  10. Satisfaction with the multimodal program [Week 4]

    Satisfaction questionnaire Scoring scale: 0-45 Higher value indicates higher satisfaction

  11. Nutritional status [Week 0 and 4]

    Nutritionist final evaluation summarized as optimal or suboptimal by the specialist.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with localized prostate cancer

  • Candidates to robotic radical prostatectomy

Exclusion Criteria:
  • Non-localized prostate cancer

  • Previous history of pelvic radiotherapy or pelvic surgery

  • Failure to consent,

  • Unwillingness to participate

  • Anticipated failure to adhere to the program sessions.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital Clinic de Barcelona Barcelona Catalonia Spain 08036

Sponsors and Collaborators

  • Hospital Clinic of Barcelona

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hospital Clinic of Barcelona
ClinicalTrials.gov Identifier:
NCT05553327
Other Study ID Numbers:
  • HCB/2021/0289
First Posted:
Sep 23, 2022
Last Update Posted:
Sep 23, 2022
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 23, 2022